Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
PI requested to close the study. No study activity since 2021 and no intent to publish results.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This will be a single center, retrospective, before-and-after, chart review of all patients undergoing TTM between June 1, 2017 and May 31, 2021 at MDMC. Initiation of the new TTM protocol occurred on April 22, 2019.
This will be a single center, retrospective, before-and-after, chart review of all patients undergoing TTM between June 1, 2017 and May 31, 2021 at MDMC. Initiation of the new TTM protocol occurred on April 22, 2019. To allow for an adequate washout period, patients who were initiated on TTM before April 22, 2019 will be in the "before" group and patients initiated on TTM on or after June 1, 2019 will be in the "after" group. Patients will be identified based on electronic medical records search of order sets utilized in TTM and confirmed with manual chart review. Statistical analysis will be performed as detailed below.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| NMB usage | vecuronium or cisatracurium | June 1, 2017 - May 31, 2021 |
| Measure | Description | Time Frame |
|---|---|---|
| NMB usage | Proportion of patients that required any vecuronium boluses Number of vecuronium boluses administered Proportion of patients that required initiation of cisatracurium infusion | June 1, 2017 - May 31, 2021 |
| Patients discharged home |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
We plan to conduct the retrospective chart review of all patients identified during the study period (from June 1, 2017 to May 31, 2021) that meet the inclusion and exclusion criteria.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tamara Reiter, PharmD | Methodist | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Methodist Dallas Medical Center | Dallas | Texas | 75203 | United States |
Not provided
| ID | Term |
|---|---|
| D006323 | Heart Arrest |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Proportion of patients discharged home
| June 1, 2017 - May 31, 2021 |
| Patients with a breakthrough fever (temperature > 38°C) in the first 72 hours of TTM initiation | Proportion of patients with a breakthrough fever (temperature > 38°C) in the first 72 hours of TTM initiation | First 72 hours of TTM initiation |
| Proportion of patients cooled to 33°C versus 36°C | number of patients at desired temperature range | June 1, 2017 - May 31, 2021 |
| Time to target temperature from initiation of TTM | time in minutes | June 1, 2017 - May 31, 2021 |
| ICU length of stay | number of days | June 1, 2017 - May 31, 2021 |